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Snake bite in southern Africa: diagnosis and management
There are three groups of venomous snakes in southern Africa – cytotoxic, neurotoxic and 
haemotoxic. 
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Venomous snakes in southern Africa can, in broad terms, be divided 
into 3 groups: cytotoxic, neurotoxic and those that can induce 
haemostatic toxic effects. However, significant overlap of these 
effects may occur. Some snake species may, for example, display 
both cytotoxicity and neurotoxicity. 
 
See Table 1 at end of article for classification, distribution, habitat 
and clinical toxinology of venomous snakes of southern Africa.
The identification of the snake responsible for the bite is usually 
difficult, unless a dead snake is brought into hospital with its victim 
and can be reliably identified. Descriptions of the snake and the 
circumstances of the bite may suggest a species diagnosis, but this is 
not often a satisfactory basis for specific treatment.  
In most cases of snake bite appropriate clinical management 
requires reliable identification of a distinctive clinical syndrome 
based on epidemiological, clinical and laboratory data. A 
syndromic approach is, therefore, recommended in the majority 
of cases. 
Main clinical syndromes
Five main clinical syndromes of snake envenoming are recognised 
in southern Africa: 
• marked local pain and progressive swelling associated with 
prominent cytotoxic skin changes with coagulable blood 
• progressive paralysis (neurotoxicity), with negligible or minor 
local swelling
• incoagulable blood, with negligible to mild local swelling
• moderate to marked local swelling, associated with neurotoxicity
• mild to moderate swelling, with negligible or absent systemic 
symptoms.
Marked local pain and progressive swelling associated with 
prominent cytotoxic skin changes with coagulable blood
Snakes responsible for this syndrome include: 
• The major adders, e.g. Bitis arietans (puff adder) and B. gabonica 
(gaboon adder) (Figs 1 and 2).
• Spitting cobras, e.g. Naja mossambica (Mozambique spitting 
cobra, M’fesi), N. nigricollis (black-necked spitting cobra), N. 
nigricincta (barred, zebra spitting cobra) and N. nigricincta 
woodi (black spitting cobra) (Figs 3 - 5). 
• The rinkhals, Hemachatus haemachatus. Although mild 
neurotoxic effects have been mentioned to occur in rinkhals bite, 
these have not been well documented (Fig. 6).
(It should be noted that extensive cytotoxicity with insignificant 
neurotoxicity has been described after South African green mamba 
bites.)
For further information with regard to the classification, 
morphology, habitat and distribution of the above-named snakes, 
see Table 1 and Figs 7 and 8. 
The toxins of cytotoxic snake venom are digestive hydrolases 
(proteolytic enzymes and phospholipases) and polypeptides that 
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destroy cell membranes, skeletal muscle and other tissues. These 
effects increase the permeability of the vascular endothelium, which 
leads to local swelling, blistering and oedema. Irreversible death of 
tissues may occur (necrosis/gangrene).
Clinical features
The local effects of bites by spitting cobras are essentially similar to 
those of large adder bites. Swelling usually begins early, often within 10 
- 30 minutes. It may become extensive, involving the entire limb and 
even adjacent areas of the trunk, especially in children. Regional lymph 
nodes may become enlarged and painful within 30 - 60 minutes. The 
aggressive and progressive cytotoxic nature of envenoming is usually 
evident within hours of the bite. Blisters and bullous skin lesions, fluid 
or blood filled, and ecchymoses often develop, at first near the fang 
marks, but may later extend beyond the bite site within 6 - 24 hours. 
‘Skip lesions’ (areas of necrosis separated by strips of apparently 
normal skin caused by proximal spread of venom in lymphatic 
vessels) are characteristic of spitting cobra bites (Fig. 10). Spitting 
cobras frequently enter dwellings at night and often bite victims 
while asleep. 
Extravasations of plasma may cause hypovolaemia, which may lead 
to hypovolaemic shock, especially in children. The local cytotoxic 
effects may progress to necrosis, with spontaneous sloughing of 
dead tissue. Compartmental syndromes may develop, especially 
Fig. 2. The large adders (vipers) have large, hinged, tubular fangs 
that can fold back into a protected sheath against the roof of the 
mouth. When attacking, the fangs are forced forward, enabling a deep 
penetrating injection of venom. (Photo: John Visser.) 
Fig. 3. Mozambique spitting cobra (Naja mossambica). Average 
length 80 - 130 cm. Above it is black grey to olive brown. Below it 
is pale or salmon pink, sometimes yellowish with crossbars, half-bars 
and blotches on the throat and anterior third of the belly. Bites are 
common. Spits and bites. (Photo: John Visser.)
Fig. 4. Barred or zebra cobra (Naja nigricincta). Average length 100 
- 120 cm. There are between 50 and 85 black crossbars on a brown 
or pinkish background. These crossbars usually encircle the body. The 
head is uniformly black both dorsally and ventrally. (Photo: Tony 
Phelps.)
Fig. 1. Puff adder (Bitis arietans). A very large, heavy-bodied snake, 
maximum total length exceeding 190 cm. Its colour may vary from 
brown, reddish to orange to very dark, with distinctive pale back edged 
U or V markings (chevron-like patterns) along the dorsum becoming 
annular rings around the tail. The belly is pale. When threatened it 
inflates its body and hisses loudly. Bites are common. (Photo: John 
Visser.)
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involving the anterior tibial compartment after bites of the feet and 
ankles, or forearm, in bites of the hand or wrist. This complication 
may lead to ischaemic necrosis of the compartmental muscles and 
nerve damage. Late (2 - 3 days post bite) haemostatic disturbances, 
especially thrombocytopenia, have been described in puff adder and 
gaboon adder bites. 
Gaboon adder bites may be accompanied by cardiovascular 
abnormalities, including hypotension, cardiac dysrhythmias and 
shock. Fortunately these bites are rare. 
Fig. 9 (a - d) shows the local toxic effects of a puff adder bite. Fig. 10 
shows the effects of spitting cobra bites. 
Special investigations
Abnormal blood biochemistry, such as raised serum concentrations 
of creatine kinase and other muscle-derived enzymes, is commonly 
found in severe envenoming because of local muscle damage. 
Neglected major adder bites may be complicated by rhabdomyolysis, 
with release of muscle contents into the plasma (myoglobinaemia), 
manifesting with myoglobinurea, which may lead to compromised 
renal function. Thrombocytopenia is also a potential complication. 
Special investigations should therefore include urinalysis, urea, 
serum creatinine, electrolytes, and full blood count (including the 
blood clotting profile). 
Snake venom ophthalmia is eye envenoming that occurs when 
venom is spat into the eyes (see under ancillary treatment).
Antivenom is available for bites of the abovementioned snakes 
(SAIMR Polyvalent Snakebite Antiserum SAVP).
Progressive paralysis (neurotoxicity), with negligible or 
minor local swelling
Snakes responsible for this syndrome include:
• Neurotoxic cobras: Naja anchietae (Anchieta’s Egyptian cobra), 
N. annulifera (banded or snouted cobra), N. melanoleuca (forest, 
black and white-lipped cobra) and N. nivea (Cape cobra) (Figs 
11 and 12). See Fig. 13 for distribution of neurotoxic cobras and 
Table 1 for classification and other information.
• Mambas: Dendroaspis polylepis (black mamba) and D. 
angusticeps (common, eastern green, white mouthed mamba). 
Fig. 5. Black spitting cobra (Naja nigricincta woodi). Average length 
120 - 150 cm; uniformly black. Spits and bites. (Photo: John Visser.)
Fig. 6. Rinkhals (Hemachatus haemachatus). Average length 1 m. 
Colour variable, but normally olive to dark brown or dull black above 
and below with one or two white crossbars on the throat. Specimens in 
the south-western and eastern Cape display numerous orange-yellow 
crossbands. (Photo: John Visser.)
Neglected major adder bites may 
be complicated by rhabdomyolysis, 
with release of muscle contents 
into the plasma (myoglobinaemia), 
manifesting with myoglobinurea, 
which may lead to compromised 
renal function.
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It should be noted that extensive cytotoxicity with insignificant 
neurotoxicity has been described after South African green 
mamba bites (Figs 14 and 15). See Fig. 16 for distribution of 
mambas and Table 1 for classification and other information.
The venoms of neurotoxic cobras contain polypeptides that compete 
with acetylcholine for binding at post-synaptic nicotinic receptors 
at skeletal muscle nerve junctions, leading to a curare-like paralysis. 
Mamba venom, in addition to its effects on post-synaptic nicotinic 
receptors, also contains polypeptide toxins, which facilitate the 
release of acetylcholine from the nerve endings (dendrotoxins), 
as well as toxins which inhibit synaptic acetylcholinesterases 
(fasciculins). Neurotoxins that block muscarinic receptors have also 
been described in mamba venom. See Fig. 4 in the article on scorpion 
sting with regard to the mechanisms of action of neurotoxic venoms 
on the peripheral nervous system. 
Clinical features
Neurotoxicity is characterised by progressive, descending flaccid 
paralysis. Early symptoms and signs include transient paraesthesia 
of the tongue and lips, blurred and double vision and ptosis, 
pupillary abnormalities (e.g. dilated pupils), external and internal 
ophthalmoplegia and paralysis of facial muscles and other muscles 
innervated by the cranial nerves, leading to dysarthria, dysphonia, 
Fig.8. Distribution of the spitting cobras and rinkhals in southern Africa.
Fig. 7. Distribution of the major adders in southern Africa. All composite maps have been compiled by GJ Müller with reference to the locations 
published in Spawls S and Branch B: The Dangerous Snakes of Africa. London: Southern Book Publishers, 1995 and Visser J: Dangerous Snakes 
and Snakebite, published by John Visser (no date).  
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and dysphagia. There is an increase in oro-pharyngeal secretions 
due to difficulty in swallowing. This is followed by progressive, 
descending paralysis, and finally respiratory failure. As respiratory 
distress increases, the patient becomes anxious, sweaty and 
cyanosed and will die unless given ventilatory support. Neurotoxic 
snakes can cause life-threatening paralysis and death within 1 - 8 
hours. Respiratory failure is usually the primary cause of death. Fig. 
17 depicts ptosis after a Cape cobra bite. 
In addition to the above neurotoxic effects, patients bitten by mambas 
may present with trembling, skeletal muscle fasciculations and signs of 
autonomic nervous system stimulation (due to increased acetylcholine 
activity in the synaptic cleft – see mechanisms above). Early features 
are vomiting, chest and limb pains and excessive salivation. Cardiac 
dysrhythmias have also been described in mamba bite victims. 
Patients bitten by elapid neurotoxic snakes may present with pain at 
the bite site and varying degrees of minor local swelling.  However, in 
some envenomed patients the bite site is difficult to locate/identify. 
Necrosis and other local cytotoxic effects do not usually develop to 
any significant degree. Fig. 18 shows minimal local swelling with Cape 
cobra bite, while Fig. 19 demonstrates that in some cases of Cape 
cobra envenomed patients the bite site is difficult to locate/identify.
Special investigations, where appropriate, should include arterial 
blood gas and other respiratory function tests and an ECG. 
Fig. 9a. Puff adder bite. Progression of local cytotoxic effects 6 hours 
post bite. 
Fig. 9b. Puff adder bite. Progressive local swelling 6 hours post bite. 
Fig. 9c. Puff adder bite 12 hours post bite. 
Fig. 9d. Puff adder bite 18 - 24 hours post bite. Swelling involving the 
whole limb extending to the lower abdomen. Note the ecchymotic skin 
lesions. 
367  CME  October  2012  Vol. 30  No. 10
Snake bite
Differential diagnosis of neurotoxic snake bite
The diagnosis of elapid neurotoxic snake bite, especially when the 
patient is unaware of being bitten or where the culprit has not been 
identified, may occasionally be difficult. Clinical conditions that 
should be considered in the differential diagnosis include scorpionism 
and latrodectism. See Table 1 in the scorpion sting article for a 
comparison of major symptoms and signs of scorpionism, latrodectism 
and neurotoxic cobra bite. In neurotoxic/cytotoxic berg adder bite 
the cytotoxic component of envenoming is quite prominent when 
compared with the minimal local effects of elapid neurotoxic snake bite.
Antivenom is available for bites of the abovementioned snakes 
(SAIMR Polyvalent Snakebite Antiserum SAVP).
Incoagulable blood, with negligible to mild local swelling
Snakes responsible for this syndrome include:
• boomslang (Dispholidus typus) (Figs 20 and 21)
• South eastern Savanna vine/bird/twig snake (Thelotornis 
capensis)
• Oate’s savanna vine snake (Thelotornis capensis oatesi). 
Fig. 21 demonstrates the position of boomslang fangs. See Fig. 22 
and Table 1 for distribution of boomslang and bird snake.
Venom of the boomslang has potent pro-coagulant effects by activating 
factors II (prothrombin), X and possibly also IX. Severe consumptive 
coagulopathy develops within several hours (4 - 24 hours) after the 
bite. See Fig. 23, in which the blood coagulation cascade is depicted.
Fig. 12. The Elapidae have rigid, hollow, short fixed fangs in the front 
of the mouth. (Photo: John Visser.)
Fig. 10. A single bite on the left hand inflicted by a barred spitting 
cobra 2 weeks previously was responsible for the ‘skip’ lesions on the 
shoulder and chest. (Photo: John Visser.) Fig. 11. Cape cobra, ‘geelslang’, ‘bruinkapel’ (Naja nivea). The average 
length is 150 - 180 cm. The colour of the Cape cobra is extremely 
variable, ranging from bright yellow, brown, reddish brown to 
black. Lighter copper-coloured specimens often have brown speckles. 
Undersurface yellowish white. All colour phases usually occur in 
one locality. Like all Elapidae, it spreads an impressive hood when 
confronted. Envenomings common in the south eastern regions of the 
country. (Photo: John Visser.)
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Clinical features
Patients may present with nausea, vomiting, abdominal pain, 
headache, dizziness and fainting. Persistent oozing of blood from 
fang punctures or other wound sites is often observed. Although 
bleeding may occur within 6 - 24 hours after a bite, systemic 
haemostatic symptoms and signs may be delayed for more than 24 
hours, even days after the bite. Bleeding usually manifests as gingival 
bleeding, epistaxis, purpura, haematemesis, melaena, haematuria, 
extensive ecchymoses, and in severe cases, subarachnoid or 
intracerebral haemorrhage. Severe consumptive coagulopathy may 
lead to multiple organ failure.There is local pain with insignificant 
or mild local swelling.  
Special investigations reveal incoagulable blood, defibrination, 
elevated fibrinogen degradation products, thrombocytopenia and 
anaemia. Incoagulable blood is a cardinal sign of consumptive 
coagulopathy. To confirm this, the ‘20 minute whole blood clotting 
test’ is a simple, rapid test of blood coagulability, which can be 
performed at the bedside and correlates well with the fibrinogen 
concentration. A few milliliters of blood taken by venepuncture 
is placed in a new, clean, dry glass vessel and left undisturbed at 
room temperature for 20 minutes, then tilted once to see whether 
or not the blood has clotted. Other more sensitive laboratory tests 
include prothrombin time (often reported as INR), thrombin 
and fibrinogen levels, activated partial thromboplastin times and 
measurement of fibrinogen degradation products and D-dimer 
concentrations. Other laboratory investigations should include 
urinalysis, full blood count, urea and electrolytes and serum 
creatinine. 
Antivenom is available for boomslang bite (SAIMR Boomslang 
Snakebite Antiserum SAVP). No antivenom is available for vine/
bird twig (Thelotornis) snake bites.
Fig. 13. Distribution of neurotoxic cobras and the sea snake in southern Africa.
Fig. 14. Black mamba (Dendroaspis polylepis). It is more heavily 
built than other mambas. Average length is 240 - 300 cm. It is coloured 
greyish brown to olive brown and never entirely black. Its name is 
derived from the colour of the inside of the mouth, which is blue-black. 
Undersurface uniform olive green. (Photo: John Visser.)
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Moderate to marked local swelling, associated with neurotoxicity 
Snakes responsible for this syndrome include:
• berg adder (Bitis atropos) (Fig. 24)
• other small/dwarf adders (side-winding adder – B. peringueyi 
and desert mountain adder – B. xeropaga).
See Fig. 25 and Table 1 for distribution and classification of the 
dwarf adders.
Phospholipase A2 neurotoxins are responsible for the toxic effects 
of these snake venoms. The neurotoxins act presynaptically, initially 
releasing acetylcholine, followed by an interference with or blockade 
of its release. 
Clinical features
After initial pain and the development of local swelling, paraesthesiae 
of the tongue and lips, blurring of vision and the loss of the sense 
of smell (anosmia) and taste, and dysphagia develop, often within 
2 - 3 hours of the bite. External and internal ophthalmoplegia 
are characterised by ptosis, fixed dilated pupils and loss of eye 
movements and accommodation.  Muscle weakness and respiratory 
failure are  common complications (in >50% of cases) and typically 
develop late (6 - 36 hours after the bite), often at a stage when not 
anticipated or expected. 
Hyponatraemia, attributable to a natriuretic hormone-like toxin 
present in the venom, is also a frequent complication. It typically 
develops late (24 - 36 hours post bite). If undetected this may lead to 
unexpected convulsions (see further under management). 
Ophthalmoplegia and anosmia may take quite a long time to 
resolve (weeks to months).
The local effects include moderate to marked local swelling. Swelling 
may involve more than half the bitten limb. Blistering and necrosis 
may develop in the region of the bite site. Extensive cytotoxic skin 
changes and compartmental syndromes are not expected to develop. 
Fig. 26 shows ptosis after a berg adder bite and Fig. 27 a berg adder 
bite demonstrating local swelling. Fig. 28 shows local necrotic 
changes after a berg adder bite.
Fig. 16. Distribution of mambas in southern Africa.
Fig. 17. Demonstration of ptosis after a Cape cobra bite.
Fig. 15. Green mamaba (Dendroaspis angusticeps). Average length 
180 - 200 cm. It is coloured uniformly bright green with undersurface 
pale green. The mouth lining is bluish white. (Photo: John Visser.)
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Recommended special investigations should include urinalysis, 
urea and electrolytes, full blood count, oxygen saturation and 
other respiratory function tests. Specific attention should be given 
to the plasma sodium level. The sodium level should be recorded 
at regular intervals until hyponatraemia is noted or until such 
time as hyponatraemia has been excluded, e.g. at 4 days after 
envenoming. 
No antivenom is available for berg adder and other dwarf adder bites.
Mild to moderate swelling, with negligible or absent 
systemic symptoms 
Snakes responsible for this syndrome include: 
• night adder (Causus rhombeatus) (Fig. 29)
• burrowing asp (Atractaspis bibronii) (Fig. 30)
• Natal black snake (Macrelaps microlepidotus)
• some dwarf adders, e.g. horned adder (Bitis caudalis) (Fig. 31).
Figs 32 and 33 show the distribution of the night adders, burrowing 
asp and the Natal black snake.
Clinical features
Associated symptoms and signs include local pain, regional 
lymphadenopathy and fever. Swelling rarely involves more than 
half of the bitten limb. Blistering and necrosis may develop at the 
bite site. Extensive cytotoxic skin changes and compartmental 
syndromes are not expected to develop. Bites by the Natal 
black snake are said to have resulted in collapse and loss of 
consciousness. 
Fig. 18. Cape cobra bite. The area shown on the foot of a paralysed 
patient 4 days after the bite, demonstrating minimal swelling. 
(Photo: John Visser.)
Fig. 19. Patient was completely paralysed 4 hours after a Cape cobra 
bite, requiring respiratory support. Note that the bite mark is difficult 
to locate on the right ankle.  
Fig. 20. Boomslang (Dyspholidus typus). Average length 120 - 150 
cm. It has a short chunky head with very large emerald green eyes. 
The colour may vary from green, brown, black to reddish, with a 
lighter belly. When cornered, they inflate the anterior part of the 
body. (Photo: John Visser.)
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Minor envenoming by spitting cobras and major adders should be 
considered in the differential diagnosis in cases where the snake has 
not been identified. Special investigations should include urinalysis 
and a full blood count. 
No antivenom is available for bites of the above-mentioned snakes.
For information with regard to envenoming by the lesser known or 
poorly documented venomous snakes (e.g. garter and coral snakes) 
consult Table 1. 
Management of snake bite 
First aid and general management 
• While instituting first aid procedures, organise transport to get 
the patient to a medical facility as soon as possible. Use a cell 
phone and other forms of communication to call for help. Alert 
the medical facility or doctor ahead of arrival. 
• Reassure the victim, who may be terrified.
• Remove constricting clothing, rings, bracelets, bands, shoes, etc. 
from the bitten limb/area.
• Immobilise the whole patient. 
• Avoid the many harmful and time-wasting traditional first-
aid treatments such as cauterisation, local incision or excision, 
tattooing, immediate prophylactic amputation of the bitten digit, 
suction by mouth or vacuum pumps or ‘venom-ex’ apparatuses, 
instillation of chemical compounds such as potassium 
permanganate, application of petrol, ice packs, ‘snake stones’ 
and electric shocks. The above measures are contraindicated as 
they are potentially harmful and none has any proven benefit. 
• In suspected neurotoxic cobra or mamba bite, especially if the 
patient is far from medical help, apply a tight crepe bandage over 
and proximal to the bite site. This procedure may reduce rapid 
distribution of the venom. Avoid crepe or other bandaging in all 
cytotoxic bites.
• The classic ‘pressure-immobilisation technique’ demands special 
equipment and training and is considered not practicable for 
general use in South Africa. 
• A tight arterial tourniquet should NEVER be used! The dangers 
of tourniquets include the development of ischaemia and 
gangrene if they are applied for more than about 1½ hours.
• Since species diagnosis is important, the dead snake should be 
taken along to hospital. However, if the snake is still at large, do 
not risk further bites.
• In suspected neurotoxic snake bites, the patient should 
be assessed regularly (e.g. every 10 - 15 minutes) for the 
development of complications of neurotoxicity. 
• Cardiopulmonary resuscitation (CPR) may be needed. This 
includes clearance of the airway, oxygen administration by face 
mask or nasal catheters, and establishment of intravenous access. 
Fig. 21. The colubridae (back-fanged snakes) have small, grooved 
fangs that are situated far back in the mouth below the eye. Species 
include the boomslang and vine snake. (Photo: John Visser.)
Fig. 22. Distribution of boomslang and bird snake in southern Africa.
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If the patient is unresponsive and no respiratory movement 
is detectable, start CPR. In case of respiratory distress/failure: 
clear the airway, lift the chin, give oxygen by face mask or nasal 
catheters with or without assisted ventilation and consider the 
need for endotracheal intubation. Shocked, hypotensive patients 
should be given intravenous fluids. Pressor agents, such as 
dopamine or phenylephrine may need to be administered. 
• Give analgesia by mouth if required: paracetamol 
(acetaminophen) or paracetamol/codeine combinations are 
preferred. Aspirin and other non-steroidal anti-inflammatory 
agents should be avoided in patients with haemostatic disorders. 
When using parenteral opioids in neurotoxic snake bite, 
respiratory function should be monitored closely. 
• In the cases of berg adder bite, hyponatraemia should not be 
treated by means of fluid restriction, but rather by a titrated 
infusion of hypertonic saline. In this respect the administration 
of normal saline may prove useful as a means of partially 
meeting both fluid and salt requirements. 
• In cases where the snake has not been identified it is 
recommended that asymptomatic patients be admitted to a 
medical facility for observations for 12 - 24 hours. 
Antivenom treatment
Two snakebite antivenoms are available:
• Polyvalent antivenom (SAIMR Polyvalent Snakebite Antiserum 
SAVP) is supplied in 10 ml ampoules. Venoms of the following 
snakes are used as antigens in the preparation of the polyvalent 
antivenom: puff adder, gaboon adder, rinkhals, green mamba, 
Fig. 24. Berg adder (Bitis atropos). The berg adder is a stoutly built 
viper, average length 30 - 40 cm. Greyish-olive to dark brown, with 
two rows of triangular black dorsal markings and an off-white belly 
with grey infusions. (Photo: John Visser.)
Extrinsic pathway
Prothrombin Thrombin
Fibrinogen Fibrin Monomers
Massive brinogen
conversion with rapid
brinogen depletion “Soluble” brin clots
without cross-linking
Severe consumptive coagulopathy
Intrinsic pathway
Clotting
Factor
Activators
XII
XI
IX
X
XIIa
XIa
IXa
Xa
Fig. 23. Blood coagulation cascade.
373  CME  October  2012  Vol. 30  No. 10
Snake bite
Jameson’s mamba, black mamba, Cape cobra, forest cobra, 
snouted cobra and Mozambique spitting cobra. Polyvalent 
antivenom is ineffective AND SHOULD NOT BE USED in 
treatment of bites caused by the berg adder, other dwarf adders, 
night adders, the burrowing asp and back-fanged snakes 
(boomslang and vine snake).
• Boomslang antivenom (SAIMR Boomslang Snakebite Antiserum 
SAVP) is supplied in 10 ml ampoules. It is effective against the 
venom of boomslang, but not against the venom of the vine snake 
(bird of twig snake). 
Antivenom neutralises a fixed amount of venom. Since snakes inject 
the same amount of venom into adults and children, the same dose/
volume of antivenom must be administered to children as in adults.
Antivenom is not always necessary: some patients are bitten by non-
venomous snakes and 10  - 50% of those bitten by venomous snakes 
are not envenomed (so called ‘dry bites’). 
Indications for antivenom treatment after bites by South African 
snakes:
• neurotoxicity
• abnormal blood clotting parameters, incoagulable blood and/or 
spontaneous systemic bleeding
• rapidly progressive and/or extensive swelling involving more 
than half the bitten limb within a few hours after the bite
• cardiovascular abnormalities such as hypotension, shock and 
cardiac arrhythmias.
Precautions
Skin testing for sensitivity is not recommended, since it is unreliable 
and only delays urgent administration of antivenom.
Administration of antivenom may be associated with acute life-
threatening adverse reactions (anaphylaxis), pyrogenic (feverish) 
reactions, or late immune complex disease (serum sickness). Most 
acute/severe allergic reactions occur during the first hour after 
antivenom administration and only a negligible number occur more 
than 6 hours post administration.
There is no absolute contraindication to antivenom treatment 
when a patient has life-threatening systemic envenoming. 
However, patients with an atopic history and those with a history 
of previous reactions to equine antisera have an increased risk 
of severe antivenom reactions. In these cases, pretreatment with 
subcutaneous adrenaline, 0.25 ml of a 1:1 000 (250 µg) solution 
in adults is justified to prevent or diminish the reaction. In 
children the dose of adrenaline is 0.01 mg/kg. Some experts 
recommend prophylactic adrenaline in all patients. Patients in 
whom adrenaline is relatively contraindicated include those 
with a history of ischaemic heart disease or stroke, uncontrolled 
hypertension and tachyarrhythmias. 
Fig. 25. Distribution of dwarf adders in southern Africa.
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Premedication with antihistamines may dampen minor allergic 
reactions but will not prevent serious allergic/anaphylactoid 
reactions. Hydrocortisone takes several hours to act and is ineffective 
as a prophylactic agent against acute reactions.
Slow infusion of the antivenom, rather than administration by 
bolus, is recommended as a method of reducing serious antivenom 
reactions (be aware of acute fluid overload in children).
Dose and methods of administration
Children should be given the same dose of antivenom as adults. 
Antivenom should be given as soon as possible once signs of systemic 
or severe local envenoming are evident. Although the polyvalent 
antivenom is more effective when given early (within 6 hours after 
the bite) it may be administered up to 24 - 48 hours or later in serious 
envenomations − it is never too late to give antivenom.
Fig. 26. Ptosis in berg adder bite. The patient is contracting the frontalis 
muscle in an attempt to open his eyes.
Fig. 27.  Prominent swelling of lower limb after berg adder bite on base 
of big toe.
Fig. 28. Berg adder bite 6 days post bite showing local necrotic changes.
Fig. 29. Night adder (Causus rhombeatus). Average length 30 - 60 
cm. The head has a distinct dark brown or black forward pointing 
V-shaped mark. There are 20 - 30 dark, pale-edged rhombic blotches 
along the back. The belly is pearly white to yellowish or light grey. 
(Photo: John Visser.)
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Antivenom is most effective when given intravenously. It should 
be diluted in isotonic fluid and infused over 30 - 60 minutes (in 
most cases a 200 ml volume container is adequate). Intramuscular 
injection is not recommended. Do not inject antivenom into or 
around the wound. 
The recommended intravenous dose of polyvalent antivenom in 
serious cytotoxic snake bite (puff adder, gaboon adder) is 50 - 100 
ml (5 - 10 ampoules). In neurotoxic snake bite (mambas, neurotoxic 
cobras) the recommended dose is 80 - 120 ml (up to 200 ml in 
severe cases of mamba bites). A follow-up dose may occasionally be 
required in black mamba bites. 
The recommended dose of boomslang antivenom is 20 ml (2 
ampoules) intravenously in isotonic fluid given over 30 minutes. A 
follow-up dose of 10 ml may sometimes be necessary. 
Response to antivenom treatment
Neurotoxic signs improve slowly after several hours (2 - 6 hours), 
often unconvincingly. It must be emphasised that the administration 
of polyvalent antivenom in the acute phase of neurotoxic snake 
envenoming will usually not prevent progression of neurotoxic 
effects, most notably respiratory paralysis, and consequently the 
patient will not survive without life support. Respiratory support 
is the only life-saving treatment modality in neurotoxic snake 
envenoming. However, intravenous administration of adequate 
doses of antivenom will decrease the time course of muscle paralysis 
and recovery. Similarly, in cytotoxic envenoming, administration of 
polyvalent antivenom will not reverse but may limit further tissue 
damage. However, in boomslang bite the haemostatic effects are 
rapidly reversed by boomslang antivenom at any time after the bite.
Treatment of antivenom reactions
Early serious reactions may begin 3 - 60 minutes after starting 
intravenous administration. Adrenaline (epinephrine) 0.1% (1:1 000) 
should be given intramuscularly in a dose of 0.5 - 1.0 ml for adults and 
0.01 mg/kg for children. This should be followed by a slow intravenous 
injection of an H1 antagonist (antihistamine) such as promethazine 
at a dose of 25 - 50 mg in adults. It is contraindicated in children 
<2 years of age. In children 5 - 10 years old the dose of promethazine 
is 6.25 -12.5 mg and in children 10 - 16 years of age 12.5 - 25 mg (or 
0.125 - 0.5 mg/kg). 
Late (serum sickness type) reactions occur 5 - 24 (average 7) days 
after treatment. It presents with itching, urticaria, fever, arthralgia, 
peri-articular swellings, proteinuria and sometimes neurological 
symptoms. Antihistamines are used for milder attacks, but in severe 
cases a short course of prednisolone should be given. 
Ancillary treatment
Although most local effects of snakebite are attributable directly 
to cytolytic and other activities of the venom itself, the bite may 
introduce pathogenic bacteria. The risk of local infections greatly 
increases if the wound has been incised with an unsterile instrument 
or tampered with in some other way. The wound should be cleaned 
with an antiseptic. Blisters and tense bullae should be aspirated only 
if rupture seems imminent.  Snake-bitten limbs should be nursed in 
the most comfortable position but should not be elevated excessively 
if there is tense swelling or suspicion of incipient intracompartmental 
syndrome, as this increases the risk of ischaemia. Debrided tissue, 
serosanguinous discharge and pus should be cultured and the 
patient treated with appropriate antimicrobials. 
Expert surgical advice should be sought where applicable.
Fig. 30. Burrowing asp or southern stilletto snake (Atractaspis 
bibronii). Average length 30 - 40 cm. Dorsally it is uniformly purple-
brown to black. Below it is creamy white or dark brown to black. When 
the snake bites, the fangs are exposed out of the side of the mouth and 
are then hooked or jabbed into the victim with a backward jerk of the 
head. (Photo: Tony Phelps.)
Fig. 31. Horned adder (Bitis caudalis). Average length 22 - 26 cm. 
Colour variable. Bluish-grey with two series of dark brown blotches 
over the back and sides in the northern areas. Olive brown with darker 
blotches in the central Cape. Reddish in Namibia. Belly always white. 
(Photo: John Visser.)
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Compartmental syndromes
These are uncommon and over-diagnosed but require urgent 
attention. The clinical appearance of snake-bitten limbs often suggests 
that there is a compartmental syndrome. There may be severe pain, 
tense swelling, cold cyanosed skin, pain on passive stretching of the 
muscles and apparently absent pulses. However, these appearances 
are usually misleading. When the intracompartmental (tissue) 
pressure is measured directly (e.g. with a Stryker monitor) pressures 
are usually found to be below the threshold of danger for ischaemic 
necrosis of the intracompartmental muscles. Should conservative 
treatment fail, full-length fasciotomy should be performed, 
providing there is no coagulopathy or gross thrombocytopenia. 
It should be mentioned that animal studies have shown that 
fasciotomy is ineffective in saving envenomed muscles. Provided 
that adequate antivenom treatment is given as soon as possible after 
the bite, fasciotomy is rarely if ever needed. 
Necrotic tissue should be debrided by a surgeon. Skin graphs may 
be necessary. 
Haemostatic abnormalities
Recovery of normal haemostatic function may be accelerated by 
giving fresh whole blood, fresh frozen plasma, cryoprecipitates or 
platelet concentrates. 
NB: Heparin and antifibrinolytic agents should never be used in 
snake bite patients. Heparin does not inhibit the abnormal thrombin 
generated by snake venoms and it exaggerates, sometimes fatally, the 
haemostatic disturbances.
Acute renal failure may be caused by haemorrhage, ischaemia resulting 
from hypotension, effects of blood clotting abnormalities, renal 
vasoconstriction, pigment nephropathy caused by haemoglobinuria 
Fig. 32. Distribution of the night adders.
Fig. 33. Distribution of the burrowing asp and the Natal black snake.
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or myoglobinuria, direct nephrotoxicity and immune complex 
glomerulonephritis caused by serum sickness reactions to antivenom. 
If the urine output falls below 400 ml in 24 hours, central venous 
pressure should be monitored and a urethral catheter inserted. 
Cautious rehydration with isotonic fluids can be followed by a high 
dose of furosemide. If these measures fail, dialysis may be indicated. 
Anticholinesterase therapy as an option for neurotoxic 
cobra bite 
Neuromusclar blockade by post-synaptic neurotoxins (e.g. 
neurotoxic cobra venom) may be partly overcome by the use of 
anticholinesterase drugs. Although anticholinesterase may assist in 
management, this should not replace antivenom therapy and should 
also not take priority over respiratory support. It may be of particular 
benefit to patients allergic to antivenom. Anticholinesterase therapy 
is, however, not recommended in bites by snakes with presynaptic 
acting neurotoxins, such as mamba or neurotoxic adders. A test dose 
of edrophonium to assess whether anticholinesterase therapy may be 
of benefit is generally recommended. However, edrophonium is not 
available in South Africa. Neostigmine is therefore used throughout. 
The administration of anticholinesterases requires the co-
administration of an anticholinergic drug to block potentially serious 
muscarinic effects, such as bradycardia, bronchospasm and an 
increase in secretions. Two anticholinergic drugs are available for this 
purpose, namely, atropine and glycopyrrolate.  Glycopyrrolate is the 
preferred anticholinergic. It gained popularity because it produces 
less tachycardia than atropine, it is a much more potent antisialagogue 
and does not cross the blood-brain barrier. It should be noted that 
reversal of blockade is difficult with concomitant respiratory acidosis. 
Hypoventilation has to be addressed to decrease the PaCO2 before 
neostigmine and glycopyrrolate will be optimally effective.  
The recommended average dosing regimen for the reversal of non-
depolarising neuromuscular blockade in adults is neostigmine 2.5 
mg and glycopyrrolate 0.6 mg (or atropine 1 mg) given together as a 
bolus. The same dosage regimen is recommended to overcome snake 
bite-induced postsynaptic blockade. It is generally recommended that 
the dose of glycopyrrolate (Robinul) be 0.2 mg (1 ml) for each 1.0 
mg of neostigmine. In children the dosage schedule of neostigmine 
for the reversal of non-depolarising neuromuscular blockade is 0.03 
- 0.07 mg/kg, maximum 2.5 mg). The average dose of glycopyrrolate 
with neostigmine is 0.010 - 0.015 mg/kg. (The recommended dose of 
atropine with neostigmine in children is 0.02 - 0.03 mg/kg.) Patients who 
respond convincingly by demonstrating increased muscle strength and/
or improvement of ptosis can be maintained on neostigmine 0.5 - 2.5 
mg every 1 - 3 hours intravenously up to 10 mg per 24 hours for adults 
or 0.01 - 0.04 mg/kg every 2 - 4 hours for children. Again, the dose of 
glycopyrrolate should be 0.2 mg (1ml) for each 1.0 mg of neostigmine.  
Snake venom ophthalmia
Snake venom ophthalmia is caused when venom is spat into the eyes. 
The spitting elapid species in southern African (Naja mossambica, N. 
nigricollis, N. nigricincta and Hemachatus haemachatus) can cause 
intense conjunctivitis and bullous corneal erosions, complicated 
by secondary infection, anterior uveitis, corneal opacities and 
permanent blindness.
First aid treatment consists of irrigating the eye or other affected 
mucous membrane as soon as possible, using large volumes of water 
or any other available bland fluid such as milk. A single application 
of local anaesthetic eye drops to overcome tightly closed eyelids 
(blepharospasm) may be used to facilitate irrigation. Topical or systemic 
antivenom treatment should not be applied or given. Corneal abrasions 
can be excluded by fluorescein staining/slit lamp examination. If there 
are no abrasions, treat with antibiotic eye ointment and an eye pad. 
Resolution should occur within 24 - 48 hours. If corneal erosions are 
present, antibiotic eye drops/ointment, mydriatics and an eye pad 
should be applied. Daily slit lamp examinations are recommended until 
resolved. An ophthalmologist should be consulted in all cases.
Further reading available at www.cmej.org.za
In a nutshell
• Five main clinical syndromes of snake envenoming are 
recognised in southern Africa: 
• marked local pain and progressive swelling associated with 
prominent cytotoxic skin changes with coagulable blood 
• progressive neurotoxicity (paralysis), with negligible or 
minor local swelling
• incoagulable blood, with negligible to mild local swelling
• moderate to marked local swelling associated with 
neurotoxicity
• mild to moderate swelling with negligible or absent 
systemic symptoms.  
• Neurotoxic snakes can cause life-threatening paralysis and 
death within 1 - 8 hours.  Respiratory failure is usually the 
primary cause of death.  
• Polyvalent antivenom is available for the management of 
mamba, neurotoxic cobra, spitting cobra and major adder 
bites. Monovalent antivenom is used in the management of 
boomslang bite.  
• Since snakes inject the same amount of venom into adults 
and children, the same dose/volume of antivenom must be 
administered to children as in adults.  
• The administration of polyvalent antivenom in the acute 
phase of neurotoxic snake envenoming will usually not 
prevent progression of neurotoxic effects, most notably 
respiratory paralysis, and consequently the patient will not 
survive without life support.  
• Respiratory support is the only life-saving treatment modality 
in neurotoxic snake envenoming.  
• Administration of antivenom may be associated with acute 
life-threatening anaphylactoid reactions.
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Table 1. Venomous snakes of southern Africa: classification, distribution, habitat and clinical 
toxinology
Family and species Common name Distribution (see figures) Clinical toxinology
Atractaspididae
(Genus Atractaspis)
African burrowing adders 
or asps (burrowing or mole 
vipers or adders, side stabbing 
or stiletto snakes), Natal black 
snake
Approximately 15 species distributed 
throughout sub-Saharan Africa 
Most cause local pain, swelling and 
lymphadenitis only; blistering, local 
necrosis described; life-threatening 
and fatal cases have been recorded
The burrowing asps are fossorial, living mostly underground in deserted termite mounds, under stones or 
logs, or in soft soil or sand. They are mostly grey, black or brown and most are relatively small (30 - 70 cm).  
They are nocturnal and usually emerge on warm, wet summer evenings, especially after heavy rains. When the 
snake bites (strikes) the fangs are exposed out of the sides of the mouth and are then hooked or jabbed into the 
victim with a backward jerk of the head. They are extremely irritable, striking in sideways swings and sweeps, 
and showing annoyance by flattening the body. Accidental bites usually occur at night when the victim treads 
on the snake.
 Atractaspis bibronii Southern, Bibron’s burrowing 
asp
Semi-desert, savanna and woodland of 
southern Africa, from Kenya through 
to eastern Tanzania, Malawi, Zambia, 
Zimbabwe, Botswana, eastern parts of 
South Africa
Local pain, swelling, lymphadenitis, 
necrosis
 Macrelaps microlepidotus Natal black snake East coast of South Africa: riverine forest 
and urban gardens
Local pain, swelling; serious cases 
recorded
Colubridae Common snakes or 
rear-fanged snakes
Wide distribution throughout Africa Venom of some capable of inducing 
fatal haemostatic defects
The back-fanged snakes have fixed, grooved rear fangs that are situated quite far back in the mouth.  Although 
only the boomslang and the vine snakes have caused fatal bites, all back-fanged colubrids should be regarded 
as potentially dangerous to man and must be handled with caution.
 Dispholidus typus Boomslang (‘tree snake’) Wide distribution throughout sub-
Saharan open bushveld and savanna
Venom contains enzymes 
which activate prothrombin 
and factor X, leading to a 
consumptive coagulopathy, severe 
hypofibrinogenaemia and fatal 
bleeding if untreated
   Thelotornis capensis capensis South-eastern savanna vine 
snake
Trees and shrubs in lowland forest to 
moist savanna and arid savanna: south-
western Zimbabwe and south- eastern 
Botswana, south through northern 
South Africa and Swaziland to southern 
Mozambique and KwaZulu-Natal
Same as for boomslang (see above)
 Thelotornis capensis oatesi Oates’ savanna vine snake Trees and shrubs in lowland forest 
to moist savanna and arid savanna: 
southern Angola and northern Namibia, 
west through northern Botswana, 
Zambia and south-east Katanga to 
Zimbabwe, western Mozambique and 
Malawi
Same as for boomslang (see above); 
no cases recorded
Elapidae The majority of elapids are long and slender. The rinkhals and the cobras are easily identified, since they usually 
rear their heads and spread a hood. Some have the ability to spit venom. There is a relatively high incidence 
of serious spitting cobra bites in Africa. The black mamba may also spread a narrow hood when threatened. 
Compared with vipers, elapids possess relatively short (up to about 10 mm long) fixed front (proteroglyphous) 
fangs. In the case of mambas, the fangs are mounted at the very front of the maxilla, and can rotate at their 
articulation with the pre-frontal bone.
Cobras, rinkhals, mambas, coral, 
shield, nose, garter and sea snakes
Wide distribution throughout Africa Potently neurotoxic and cytotoxic; 
common cause of fatal snake bite
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Family and species Common name Distribution (see figures) Clinical toxinology
Neurotoxic cobras 
(genus Naja)
Naja anchietae Anchieta’s Egyptian cobra Arid savanna: Namibia, Angola, 
north-western Botswana, south-west 
Zambia
Potently neurotoxic; see below as for N. 
nivea
Naja annulifera Banded cobra Arid and moist savanna: northern 
South Africa, eastern Botswana and 
Zimbabwe
Potently neurotoxic; see below as for N. 
nivea
Naja melanoleuca Forest, black and white-lipped 
cobra
Forrested areas of West and Central 
Africa, southern East Africa and 
eastern coast of South Africa
Potently neurotoxic; see below as for N. 
nivea
Naja nivea Cape cobra Karoo scrub, arid savanna, Namib 
desert: western part of South Africa, 
southern Namibia and Botswana
Potently neurotoxic, causing flaccid 
paralysis and respiratory failure; fatalities 
common due to respiratory arrest
Spitting or cytotoxic 
cobras (genus Naja)
Naja mossambica Mozambique spitting cobra, 
M’fesi
Moist savanna and lowland forest: 
south-east Africa, from Pemba to 
northern South Africa and Namibia
Potently cytotoxic; spits and bites; severe 
local pain, swelling, tissue necrosis, often 
extensive; eye envenoming
 Naja nigricollis: species 
under review
Naja nigricollis nigricollis Black-necked spitting cobra Savanna, from West Africa to 
southern Sudan and southwards, 
through West Africa to Angola
Potently cytotoxic; spits and bites; as in N. 
mossambica
Naja nigricincta Barred, zebra spitting cobra Namib desert and Karoo scrub: 
southern coastal Angola and 
northern Namibia
Potently cytotoxic; spits and bites; as in N. 
mossambica
Naja nigricincta woodi Black spitting cobra Dry savanna: southern Namibia, 
Northern Cape and down to Western 
Cape Province of South Africa
Potently cytotoxic; spits and bites; as in N. 
mossambica
Coral/shield-nose 
snakes
(genus Aspidelaps)
Relatively small, robust elapids easily recognised by the much enlarged, shield-like rostral scale on the snout. 60 - 
80 cm in size. A relatively thick-bodied elapid coloured black and orange or greyish with blackish bands. It rears 
up, spreads a narrow hood and hisses in defence.
 Aspidelaps lubricus.  Three coral snake sub-species 
recognised:  Aspidelaps lubricus lubricus (southern race), 
Aspidelaps lubricus infuscatus (central race) and Aspidelaps 
lubricus cowlesi (northern race)
Desert and arid savanna: south-
western South Africa, through 
Namibia to southern Angola
Local pain, swelling, lymphangitis; mildly 
neurotoxic;  bites not well documented
Aspidelaps scutatus.  Three shield-nose snake subspecies 
(races) recognised: Aspidelaps scutatus scutatus (western 
race), Aspidelaps scutatus fulafula (eastern race) and 
Aspidelaps scutatus intermedius (central race)
Sandy and stony regions in Namib 
desert, moist and arid savanna, across 
northern regions of southern Africa, 
from Namibia across to Mozambique
Details contradictory; local pain, swelling 
and lymphangitis in some of the bites; 
neurotoxic in others, with one fatality
Mambas (genus 
Dendroaspis)
Large, agile, slender diurnal elapid snakes with a long flat-sided head, a medium-sized eye and a round pupil. 
Scales are smooth and narrow. All except the black mamba (Dendroaspis polylepis) are arboreal. Colouration varies 
from light green to olive brown and dark grey. 1.5 - 3.5 m in size. Coffin-shaped head. The black mamba may 
spread a narrow hood.
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Family and species Common name Distribution (see figures) Clinical toxinology
Dendroaspis angusticeps Common, eastern green, 
white-mouthed mamba
Forests or bush on eastern coast of 
Africa, from Kenya to South Africa
Local pain, swelling, lymphangitis, 
peripheral gangrene; mildly neurotoxic; one 
fatal case
Dendroaspis polylepis Black mamba Savanna of eastern and southern 
Africa
Potently neurotoxic; nausea, vomiting, 
sweating, involuntary muscle contractions 
or fasciculations; respiratory paralysis 
may develop within 1 - 2 hours; cardiac 
dysrhythmias have been described; high 
incidence of fatal cases
Garter snakes 
(genus Elapsoidea)
 
Taxonomy under revision; 
several subspecies
Small fossorial, nocturnal elapid snakes, with very short tails, cylindrical bodies, with no distinct neck and a 
bluntly rounded rostral scale as in other burrowing species. Most have an average length of 25 - 50 cm. The young 
are brightly banded (except for one species), the bands fading as they grow. Sluggish when exposed and do not bite 
if handled gently.
Elapsoidea semiannulata Angolan or half-banded 
garter snake
Savanna: Senegal to northern Uganda 
and a separate southern population 
from Angola to Mozambique
Local pain, swelling and lymphangitis
Elapsoidea sundevallii Sundevall’s garter snake Karoo scrub to arid savanna, moist 
savanna, grassland and lowland 
forest: southern Africa
Local pain, swelling and lymphangitis; 
neurotoxic?
Other Elapidae
Hemachatus haemachatus Rinkhals Wide variety of habitats; grassland, 
moist savanna, lowland forest: 
eastern regions of South Africa;  
isolated population in south-western 
Zimbabwe
Bites and spits; local swelling and bruising.  
Mildly neurotoxic?
Pelamis platurus Pelagic, yellow-bellied sea 
snake
East coast of Africa, from Djibouti to 
Cape Town
Neurotoxic and myotoxic; myoglobinuria; 
bites are rare
Viperidae Adders and vipers Approximately 45 species distributed 
throughout Africa
Cytotoxic, haemostatic disorders, neurotoxic; 
common cause of life-threatening and fatal 
snake bite in Africa
Vipers or adders are relatively thick bodied, sluggish, mainly terrestrial snakes which have long, curved, 
cannulated and fully erectile fangs which fold down against the upper jaw in a mucous membrane sheath when the 
snake is not striking.
Large adders (genus 
Bitis)
Wide head and narrow neck. The tail appears oddly short in females and only less so in males. The four larger 
species have a total length of 80 cm – 2 m. The puff adder is the most widespread and unmistakable; body stout 
and massive; brown or greyish with well-marked chevron markings. Medically, one of the most important snakes 
in Africa. The small adders of southern Africa have an average length of 20 - 50 cm.
Bitis arietans arietans Puff adder Wide variety of habitat, savanna 
and open grassland, except in high 
montane grasslands, true desert and 
rainforest: widespread throughout 
sub-Saharan Africa, absent in African 
rain forests
Potently cytotoxic; severe local pain, 
extensive swelling and blistering, 
compartmental syndrome, necrosis, 
hypovolaemia, shock; blood coagulation 
abnormalities
Bitis gabonica Gaboon adder or viper, 
forest puff adder
Tropical forests of West, Central 
and East Africa, and eastern parts of 
southern Africa
Local effects as above; cardiovascular and 
haemostatic abnormalities may develop
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Family and species Common name Distribution (see figures) Clinical toxinology
Small (dwarf) adders 
(genus Bitis)
Bitis atropos Berg adder Montane fynbos and grasslands: 
mountains of eastern Zimbabwe, 
Drakensberg mountains down to 
mountains of south-western Cape
Cytotoxic and neurotoxic; local pain, swelling 
and lymphangitis, ophthalmoplegia, anosmia, 
hyponatraemia, life-threatening respiratory 
depression in some cases
Bitis caudalis Horned adder Arid savanna and desert: arid regions 
of south-west Africa, extending 
eastwards through Botswana to 
northern South Africa and southern 
Zimbabwe
Local pain and swelling (this may be extensive 
with necrosis) lymphangitis
Bitis peringueyi Peringuey’s adder, side-
winding adder
Namib desert, Namibia Local pain, swelling and lymphangitis; 
ophthalmoplegia and other minor neurotoxic 
effects observed
Bitis schneideri Namaqua dwarf adder, 
Schneider’s adder
Vegetated coastal sand: coastal regions 
of southern Namibia and northern 
Cape Province
Local pain, swelling and lymphangitis
Bitis xeropaga Desert mountain adder Sparsely vegetated rocky hillsides and 
mountain slopes: southern Namibia 
and adjacent small area across Orange 
River into South Africa
Local pain and swelling; ophthalmoplegia 
and other minor neurotoxic effects observed; 
hyponatraemia
Other small adders (vipers) considered venomous, but for which no bites have been recorded:  Bitis albanica (Albany adder): 
isolated population in the Algoa Bay region, eastern Cape, South Africa; Bitis armata (Southern adder): two isolated populations on the 
coast of the Western Cape, South Africa; Bitis cornuta (many-horned adder, hornsman): coastal regions of south-western and western South 
Africa to southern Namibia, Bitis heraldica (Angolan adder): high parts of central Angola; Bitis inornata (plain mountain adder): isolated 
populations in the Graaff Reinet region of the Eastern Cape, South Africa; Bitis rubida (red adder): southern to south-western part of South 
Africa: Cederberg, through Little Karoo and foothills of the Roggeveld and Komsberg.
 Night adders (genus 
Causus)
The night adders are small (<1 meter) and despite their name they are active by day and by night. They are not 
adder-like, and are fairly stout with the head being only slightly distinct from the neck. The venom fangs are short 
with no hinge action compared with the genus Bitis. They have round pupils (most adders have vertical eye pupils) 
and they have large scales on top of the head (most vipers have small scales). They are not given to standing their 
ground, but when angry, they hiss and puff ferociously, inflating the body to great extent. They may also raise the 
forepart of the body off the ground and slide forward with the neck flattened, looking quite cobra-like.
Causus defilippii Snouted night adder Moist and dry savanna and coastal 
thicket: eastern Africa, from Kenya and 
Tanzania, Malawi, Zambia, Zimbabwe 
and Mozambique to north-eastern 
South Africa
Local pain, swelling, lymphangitis and local 
necrosis
Causus rhombeatus Eastern rhombic night 
adder
Savanna, from eastern Nigeria, through 
Central Africa, down to eastern half of 
South Africa
Local pain, swelling, lymphangitis and local 
necrosis
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